510(k) Report

510(k) · Cleared

Cleared

Modification to Hyperglide Occlusion Balloon System

K021066510(k) TraditionalCleared Jun 18, 200277-day reviewClass II21 CFR 870.4450

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Micro Therapeutics, Inc. · MJN Catheter, Intravascular Occluding, Temporary

Cleared on Jun 18, 2002 after a 77-day review. The FDA summary names its predicate without a number. 11 later devices descend from it.

Decided
Jun 18, 2002
Review
77 days
Class
Class II
Product code
MJN
Recalls
None
Predicates
0

11 later devices descend from it, 4 citing it directly.

Descendants, by year cleared 2009: 3 descendants cleared2010: 2 descendants cleared2013: 1 descendant cleared2011: 1 descendant cleared2012: 2 descendants cleared2019: 2 descendants cleared200020052010201520202025
  1. This deviceK021066 Modification to Hyperglide Occlusion Balloon SystemMicro Therapeutics, Inc. · 2002
  2. Descendant · cites it directly · 10 of its ownK090728 Hyperglide Occlusion Balloon SystemEv3, Inc. · 2009
  3. Descendant · 2 generations on · 8 of its ownK091458 Hyperglide Occlusion Balloon System, Hyperform Occlusion Balloon…Ev3 Neurovascular · 2009
  4. Descendant · 3 generations on · 4 of its ownK110741 Scepter C Occlusion Balloon CatheterMicroVention, Inc. · 2011
  5. Descendant · 4 generations on · 3 of its ownK113698 Scepter XC Occlusion Balloon CatheterMicroVention, Inc. · 2012
  6. Descendant · cites it directly · 3 of its ownK092495 Hyperglide Occlusion Balloon System, Model 104-4310, 104-4315Ev3 Neurovascular · 2009

Showing 5 of 11 descendants. See all descendants

Descendants cleared per year

2009: 32010: 22011: 12012: 22013: 12019: 2
2009high 3 (2009) · low 0 (2014)2026

Most influential descendants

Showing 5 of 11 · See all
  • K090728Hyperglide Occlusion Balloon SystemEv3, Inc. · 2009 · cites it directly10descendants
  • K091458Hyperglide Occlusion Balloon System, Hyperform Occlusion Balloon System, Model 104-4112…Ev3 Neurovascular · 2009 · 2 generations on8descendants
  • K110741Scepter C Occlusion Balloon CatheterMicroVention, Inc. · 2011 · 3 generations on4descendants
  • K113698Scepter XC Occlusion Balloon CatheterMicroVention, Inc. · 2012 · 4 generations on3descendants
  • K092495Hyperglide Occlusion Balloon System, Model 104-4310, 104-4315Ev3 Neurovascular · 2009 · cites it directly3descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K021066Modification to Hyperglide Occlusion Balloon SystemMicro Therapeutics, Inc.2002—
+1K090728Hyperglide Occlusion Balloon SystemEv3, Inc.2009—
+2K091458Hyperglide Occlusion Balloon System, Hyperform Occlusion Balloon System, Model…Ev3 Neurovascular2009—
+3K110741Scepter C Occlusion Balloon CatheterMicroVention, Inc.2011—
+4K113698Scepter XC Occlusion Balloon CatheterMicroVention, Inc.2012—
+1K092495Hyperglide Occlusion Balloon System, Model 104-4310, 104-4315Ev3 Neurovascular2009—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200930
201020
201110
201220
201310
201920
FIG. 1 — Lineage of K021066, 2002–2019Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MJN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MJN device

  1. #1 K243795 pREBOA-PRO Catheterscore 12.1 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—MTI Equinox Occlusion Balloon Catheter
Named without a submission number
—

What descends from it? (11)

See all 11

4 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K090728Hyperglide Occlusion Balloon SystemEv3, Inc.200910
K092495Hyperglide Occlusion Balloon System, Model 104-4310, 104-4315Ev3 Neurovascular20093
K100063Hyperform Occlusion Balloon Catheter, Hyperglide Occlusion Balloon Catheter, Hyperglide…Ev3, Inc.20102
K101570Hyperglide and Hyperform Occlusion Balloon SystemsMicro Therapeutics Dba Ev3 Neurovascular20101

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K090728 (Ev3, Inc., 2009) has gone furthest, with 10 descendants of its own.

How does its category compare?

All MJN devices

MJN Catheter, Intravascular Occluding, Temporary: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · MJN

2in 2025

2007: 22008: 32009: 52010: 52011: 42012: 22013: 42014: 22015: 42016: 32017: 32018: 32019: 32020: 42021: 42022: 22023: 12025: 2
2007high 5 (2009) · low 0 (2024)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MJN

116in 2021

2008: 153 days median2009: 39 days median2010: 30 days median2011: 69 days median2013: 87 days median2015: 245 days median2016: 110 days median2017: 54 days median2018: 63 days median2019: 117 days median2020: 64 days median2021: 116 days median
2007high 245 (2015) · low 30 (2010)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MJN

1in 2020

2008: 22010: 12011: 12013: 82015: 12016: 22018: 12020: 1
2007high 8 (2013) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MJN

194in 2025

2007: 252008: 262009: 252010: 352011: 922012: 532013: 762014: 1002015: 902016: 712017: 1572018: 1072019: 1392020: 1572021: 1582022: 1482023: 1812024: 2242025: 194
2007high 224 (2024) · low 25 (2007)2025

MAUDE reports naming product code MJN, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—025
20083153226
2009539025
2010530135
2011469192
20122—053
2013487876
20142—0100
20154245190
20163110271
20173540157
20183631107
201931170139
20204641157
202141160158
20222—0148
20231—0181
20240—0224
20252—0194
20260—0—

What is it indicated for?

The MTI HyperGlide Occlusion Balloon Catheter is indicated for use in the blood vessels of the peripheral and neuro vasculature where temporary occlusion is desired.

The MTI Modified Occlusion Balloon Catheter offers a vessel selective technique of temporary vascular occlusion, which is useful in selectively stopping or controlling blood flow.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K021066: Modification to Hyperglide Occlusion Balloon System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K021066

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026